WASHINGTON, Oct. 9, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achi

Evolent Health, Inc (NYSE: EVH - Get Free Report) has received a consensus recommendation of "Modera

JP Morgan analyst John Stansel maintains Evolent Health (NYSE:EVH) with a Overweight and raises t

TD Cowen analyst Charles Rhyee maintains Evolent Health (NYSE:EVH) with a Buy and raises the pric

Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Hold and low

Citigroup analyst Daniel Grosslight upgrades Evolent Health (NYSE:EVH) from Neutral to Buy and lo

Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's af

Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and lowers

Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 86.9% to $1.25 during Thursday's

Evolent Health (NYSE:EVH) raises FY2026 sales outlook from $2.400 billion-$2.600 billion to $2.600 b

Evolent Health (NYSE:EVH) reported quarterly earnings of $0.02 per share which beat the analyst cons

TD Cowen analyst Charles Rhyee maintains Evolent Health (NYSE:EVH) with a Buy and lowers the pric

Citigroup analyst Daniel Grosslight downgrades Evolent Health (NYSE:EVH) from Buy to Neutral and

Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and raises

Truist Securities analyst Jailendra Singh downgrades Evolent Health (NYSE:EVH) from Buy to Hold a

Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Buy and rais

Stocks had mixed performance on Thursday, Dow Jones up 793 points while Nasdaq down 232 points. Rumb

Citigroup analyst Daniel Grosslight maintains Evolent Health (NYSE:EVH) with a Buy and raises the

Needham analyst Matthew Shea maintains Evolent Health (NYSE:EVH) with a Buy and raises the price

Evolent Health (NYSE:EVH) affirms FY2026 sales outlook from $2.400 billion-$2.600 billion to $2.400

Evolent Health (NYSE:EVH) reported quarterly losses of $(0.02) per share which beat the analyst cons

U.S. stocks were lower, Dow Jones fell 0.1% on Monday. XOMA shares rose on Ligand's plans to acq

Oppenheimer analyst Michael Wiederhorn maintains Evolent Health (NYSE:EVH) with a Outperform and

Citigroup analyst Daniel Grosslight maintains Evolent Health (NYSE:EVH) with a Buy and lowers the

UBS analyst Kevin Caliendo maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price ta

Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Buy and lowe

Needham analyst Matthew Shea maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price

RBC Capital analyst Ryan Halsted maintains Evolent Health (NYSE:EVH) with a Sector Perform and lo

BTIG analyst David Larsen maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price tar

Evolent Health (NYSE:EVH) reported quarterly earnings of $0.08 per share which beat the analyst cons

Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings

Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarte

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear

Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimat

Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its

Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for i

U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Tuesday. Here are some